Rautamo Maria, Kvarnström Kirsi, Sivén Mia, Airaksinen Marja, Lahdenne Pekka, Sandler Niklas
HUS Pharmacy, HUS Helsinki University Hospital, Stenbäckinkatu 9 B, 00290 Helsinki, Finland.
Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, 00014 Helsinki, Finland.
Pharmaceutics. 2020 Mar 5;12(3):229. doi: 10.3390/pharmaceutics12030229.
The utilization of three-dimensional (3D) printing technologies as innovative manufacturing methods for drug products has recently gained growing interest. From a technological viewpoint, proof-of-concept on the performance of different printing methods already exist, followed by visions about future applications in hospital or community pharmacies. The main objective of this study was to investigate the perceptions of healthcare professionals in a tertiary university hospital about oral 3D-printed medicines for pediatric patients by means of focus group discussions. In general, the healthcare professionals considered many positive aspects and opportunities in 3D printing of pharmaceuticals. A precise dose as well as personalized doses and dosage forms were some of the advantages mentioned by the participants. Especially in cases of polypharmacy, incorporating several drug substances into one product to produce a polypill, personalized regarding both the combination of drug substances and the doses, would benefit drug treatments of several medical conditions and would improve adherence to medications. In addition to the positive aspects, concerns and prerequisites for the adoption of 3D printing technologies at hospital settings were also expressed. These perspectives are suggested by the authors to be focus points for future research on personalized 3D-printed drug products.
三维(3D)打印技术作为药品创新制造方法的应用近来越来越受到关注。从技术角度来看,不同打印方法性能的概念验证已经存在,随之而来的是对其在医院或社区药房未来应用的展望。本研究的主要目的是通过焦点小组讨论,调查一所三级大学医院的医护人员对儿科患者口服3D打印药物的看法。总体而言,医护人员认为3D打印药物有许多积极方面和机遇。精确剂量以及个性化剂量和剂型是参与者提到的一些优点。特别是在多重用药的情况下,将几种药物成分整合到一种产品中制成多药丸,在药物成分组合和剂量方面实现个性化,将有益于多种病症的药物治疗,并提高用药依从性。除了积极方面,也表达了在医院环境中采用3D打印技术的担忧和前提条件。作者建议这些观点作为未来个性化3D打印药品研究的重点。